Lab-grown lung organoids mimic human counterpart

Researchers at Columbia University Medical Center (CUMC) in New York have successfully grown lung organoids from human pluripotent stem cells. These 3D structures that mimic a fully-grown lung aim to improve research into respiratory diseases.

These organoids are the first to feature branching airway and alveolar structures similar to human lungs. Researchers, who have published work in Nature Cell Biology, hope to improve research models and drug development into regenerating tissue.

"Researchers have taken up the challenge of creating organoids to help us understand and treat a variety of diseases," said Hans-Willem Snoeck, PhD, professor of medicine in microbiology and immunology at CUMC and lead investigator of the study. "But we have been tested by our limited ability to create organoids that can replicate key features of human disease."

Snoeck and his team were able to create organoids that mimicked lung reactions to respiratory syncytial virus (RSV) and pulmonary fibrosis. These mimicked reactions to diseases with complex treatments give researchers the ability to test possible drug solutions.

"Organoids, created with human pluripotent or genome-edited embryonic stem cells, may be the best, and perhaps only, way to gain insight into the pathogenesis of these diseases," said Snoeck.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup